Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Boerner

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Psychiatrische Praxis|January 1, 1996
[Organic catatonic disorder--on the occurrence of a catatonic syndrome in a patient with encephalomyelitis disseminata]R J Boerner
Der Nervenarzt|March 1, 1995
[Integrated treatment strategies in panic disorder with agoraphobia and depressive disorder]R J Boerner
Psychiatrische Praxis|January 1, 1995
[Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy]R J Boerner
MMW Fortschritte Der Medizin|June 23, 2005
[Panic attacks and panic disorder: recognition and treatment]R J Boerner
Journal of Medical Education|December 1, 1983
Financial assistance for medical students, 1982-83R J Boerner, J W Bickel
International Journal of Psychiatry in Clinical Practice|June 20, 2014
Therapeutic strategies for patients with social phobiaR J Boerner, H J Möller
European Archives of Psychiatry and Clinical Neuroscience|June 16, 1999
Psychopathological changes and cognitive impairment in encephalomyelitis disseminataR J Boerner, H P Kapfhammer
The Journal of Biological Chemistry|August 15, 1993
Isotopic labeling and EPR spectroscopy show that a tyrosine residue is the terminal electron donor, Z, in manganese-depleted photosystem II preparationsR J Boerner, B A Barry
International Journal of Psychiatry in Clinical Practice|June 14, 2014
The value of selective serotonin re-uptake inhibitors (SSRIs) in the treatment of panic disorder with and without agoraphobiaR J Boerner, H J Möller
The Journal of Biological Chemistry|January 7, 1994
EPR evidence that the M+ radical, which is observed in three site-directed mutants of photosystem II, is a tyrosine radicalR J Boerner, B A Barry
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Psychiatrische Praxis|January 1, 1996
[Organic catatonic disorder--on the occurrence of a catatonic syndrome in a patient with encephalomyelitis disseminata]R J Boerner
Der Nervenarzt|March 1, 1995
[Integrated treatment strategies in panic disorder with agoraphobia and depressive disorder]R J Boerner
Psychiatrische Praxis|January 1, 1995
[Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy]R J Boerner
MMW Fortschritte Der Medizin|June 23, 2005
[Panic attacks and panic disorder: recognition and treatment]R J Boerner
Journal of Medical Education|December 1, 1983
Financial assistance for medical students, 1982-83R J Boerner, J W Bickel
International Journal of Psychiatry in Clinical Practice|June 20, 2014
Therapeutic strategies for patients with social phobiaR J Boerner, H J Möller
European Archives of Psychiatry and Clinical Neuroscience|June 16, 1999
Psychopathological changes and cognitive impairment in encephalomyelitis disseminataR J Boerner, H P Kapfhammer
The Journal of Biological Chemistry|August 15, 1993
Isotopic labeling and EPR spectroscopy show that a tyrosine residue is the terminal electron donor, Z, in manganese-depleted photosystem II preparationsR J Boerner, B A Barry
International Journal of Psychiatry in Clinical Practice|June 14, 2014
The value of selective serotonin re-uptake inhibitors (SSRIs) in the treatment of panic disorder with and without agoraphobiaR J Boerner, H J Möller
The Journal of Biological Chemistry|January 7, 1994
EPR evidence that the M+ radical, which is observed in three site-directed mutants of photosystem II, is a tyrosine radicalR J Boerner, B A Barry
Pageof 4